Trehalose
Trehalose is a dietary supplement with 12 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
2
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.0%
3 of 4 finished
25.0%
1 ended early
1
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Clostridium Butyricum in Stenosing Crohn's Desease
Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction
Intermediate-Sized Expanded Access Study
The Effect of a Pre-cataract Surgical Ocular Hygiene Regime on Microbial Load, Tear Osmolarity, Dry Eye, and Inflammatory Markers
Trehalose as add-on Therapy in Bipolar Depression
Clinical Trials (12)
Clostridium Butyricum in Stenosing Crohn's Desease
Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction
Intermediate-Sized Expanded Access Study
The Effect of a Pre-cataract Surgical Ocular Hygiene Regime on Microbial Load, Tear Osmolarity, Dry Eye, and Inflammatory Markers
Trehalose as add-on Therapy in Bipolar Depression
Efficacy Of Oral Trehalose In Spinocerebellar Ataxia 3
Efficacy of Oral Administration of Trehalose in Patients With Parkinson Disease
Mycose AdminiStration for HealIng Alzheimer NEuropathy (MASHIANE)
Inflammation Reduction by TREhalose AdminisTration
Clinical Effects of Oral Trehalose In Patients With Spinocerebellar Ataxia 3
Treatment of Oculopharyngeal Muscular Dystrophy With Trehalose
Clinical Study of 12-week Trehalose Intake in Patients With Fatty Liver Disease
All 12 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 12